LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea

On March 19, 2026, LivaNova PLC (NASDAQ:LIVN) announced that the FDA granted premarket support for its aura6000 System for treating adults with mean to terrible obstructive slumber apnea. The strategy uses proximal hypoglossal nervus stimulation to code patients with an apnea-hypopnea scale of 15 to 65 who are incapable to usage oregon bash not respond to first-line therapies specified arsenic affirmative airway pressure.

Last month, Barclays raised its terms people connected LivaNova to $73 from $67 and maintained an Equal Weight standing pursuing a Q4 net beat. Baird besides raised its terms people to $83 from $75 and kept an Outperform rating, saying updated estimates suggest 2026 could beryllium different beat-and-raise year. Mizuho raised its terms people to $85 from $72 and maintained an Outperform rating, citing a coagulated outlook for 2026.

The standing updates followed LivaNova’s Q4 results, wherever the institution reported adjusted EPS of 86c versus the 81c statement estimation and gross of $360.9M compared with $354.31M expected. CEO Vladimir Makatsaria said 2025 delivered “double-digit gross growth” on with borderline enlargement and beardown currency generation, driven by execution successful its halfway businesses. Makatsaria added that the institution is investing successful its OSA level to participate a high-growth marketplace portion maintaining momentum crossed its existing segments.

LivaNova PLC (NASDAQ:LIVN) develops and markets aesculapian technologies and therapies crossed aggregate planetary healthcare markets.

While we admit the imaginable of LIVN arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double successful 3 Years and 15 Stocks That Will Make You Rich successful 10 Years.

Disclosure: None. Follow Insider Monkey connected Google News.